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Abstract 
 
Background: Preoperative bathing or showering with an antiseptic solution is used 
to prevent surgical site wound infection. Conflicting trial results suggest a critical 
review is necessary.  
Methods: We systematically reviewed randomized controlled trials. Studies were 
identified by computer searches of Medline, Embase and the Cochrane controlled 
trials register. Trials were eligible if they compared pre-operative bathing or 
showering using an antiseptic solution with a non-antiseptic wash agent or with no 
shower, and if they reported data on surgical site infection. 
Results: Six trials involving a total of 10,007 participants were included. 4% 
chlorhexidine gluconate (Hibiscrub) was used in all trials. Three trials involving 7691 
participants compared Hibiscrub with a placebo. Bathing with chlorhexidine did not 
reduce surgical site wound infection rate; the relative risk (RR) was 0.91 (95% 
confidence interval (CI) 0.80 to 1.04). When only trials of high quality were included 
in this comparison, the RR was 0.95 (95% CI 0.82 to 1.10). Three trials of 1443 
participants compared bar soap with chlorhexidine; no differences in the surgical site 
infection rates were detected, the RR was 1.02 (95% CI 0.57 to 1.84). Two trials of 
1092 patients compared bathing with chlorhexidine with no washing. The surgical site 
wound infection rate in the two groups was similar, the RR was 0.70 (95% CI 0.19 to 
2.58).  
Conclusions: Current evidence does not support pre-operative showering or bathing 
with chlorhexidine to reduce surgical site wound infection rates.  
 
Background 
Surgical site infection is the third most frequent nosocomial infection (1). According to 
the Centers for Disease Control and Prevention, approximately three per cent of 
15,523 wound surveyed became infected, 551of these patients died, and 77% of 
deaths were attributed to the infection (2). Apart from the morbidity and mortality 
associated with surgical site infections, there are significant cost implications. A 
recent study, using the National Nosocomial Infection Surveillance (NNIS) index 
found that it cost over US$3000 more to treat a patient with a surgical site infection 
than a patient without a surgical site infection. These costs were attributable to a 
greater likelihood of admission to an intensive care unit, a longer than usual post-
operative stay (five days) and an increased rate of hospital re-admission (3). 
Potential litigation is also a concern (4). Consequently, prevention of surgical site 
infection has become a priority for health care facilities.  
 
One of the widely used strategies to prevent surgical site infection is whole body 
bathing or showering with a skin antiseptic before surgery. The aim of washing is to 
make the skin as clean as possible by removing transient flora and some resident 
flora. Chlorhexidine 4% in detergent ('Hibiscrub' or 'Hibiclens') or a triclosan 
preparation is usually used for this purpose, and there is evidence that the numbers 
of bacteria on the skin are reduced when it is applied (5, 6). Moreover, use of a skin 
antiseptic on consecutive days not only reduces microbial counts from baseline 
measurements, but also reduces the counts progressively over time (7). Although 
this body of evidence demonstrates the effectiveness of antiseptics as skin cleansing 
agents, the more important question is whether preoperative bathing or showering 
with an antiseptic reduces the incidence of surgical site infection.  
 
In a 10-year prospective surveillance study, the surgical site infection rate was lower 
amongst patients showering with hexachlorophene before surgery than in those who 
either did not shower or showered using a non-medicated soap (8). In addition, at 
least two studies have used a before and after design to test the effect of introducing 
preoperative showering with triclosan to control methicillin-resistant Staphylococcus 
aureus (MRSA) surgical site infections. In the first of these, showering before and 
after surgery was introduced to reduce the MRSA surgical site infection rate. 
However, this intervention was only one of a battery of measures introduced, so it 
was not possible to determine the independent effect of preoperative showering (9). 
In the second, the incidence of MRSA surgical site infection was reduced amongst 
orthopaedic patients after presurgical showering with triclosan was introduced, 
however, the patients were also treated with nasal mupirocin for five days before 
surgery (10). While these observational studies provide some support for the practice 
of preoperative showering with an antiseptic, the evidence remains controversial.  
 
Patterns of resistance have developed with some antiseptics (11), leading to calls to 
restrict their use to situations where effectiveness can be demonstrated. In addition, 
hypersensitivity to chlorhexidine is not uncommon. Consequently, the potential 
benefit of bathing/showering with antiseptics needs to be assessed alongside the 
potential for harm (12, 13). As it is unclear whether the use of antiseptics for 
preoperative bathing or showering leads to lower rates of surgical site infection, a 
systematic review is justified to guide practice in this area.  
 
Methods 
The primary objective of this study was to assess whether preoperative bathing or 
showering with antiseptics decreased the rate of nosocomial surgical site infection. 
Secondary analyses included mortality, allergic reactions and cost. 
 
Search Strategy 
We used the standard methodology of the Cochrane Collaboration (14). Studies were 
identified using the Cochrane Wounds Group Specialised Register (December 2005) 
which is maintained by searching MEDLINE, CINAHL and EMBASE; the Cochrane 
Central Register of Controlled Trials (CENTRAL Issue 4 2005); and hand searching 
of wound care journals and relevant conference proceedings. There was no 
restriction by language or date of publication. Reference lists of all retrieved articles 
were searched for additional studies. Manufacturers of antiseptic products were 
contacted in order to obtain any unpublished data. In addition, we searched 
MEDLINE (2002 to December 2005) to allow for any lag-time in the Wounds Group 
Specialised Register using the following search strategy: exploded MESH (medical 
subject headings) terms (‘detergents’, ‘povidone-iodine’, ‘chlorhexidine’, disinfection’, 
‘alcohol detergents’, ‘anti-infective agents’, ‘local surgical wound infection’, 
‘preoperative care’ and ‘perioperative care’) and specific text-word terms  detergent$, 
Betadine, chlorhexidine, ‘povidone iodine’, ‘alcohol$’, ‘soap’, ‘antiseptic$, ‘iodophor$’, 
wound infection$’, ‘shower$’, ‘bath$’ and ‘clean’. The dollar sign was used to retrieve 
all possible derivations of the root words. 
 
Eligibility criteria 
All published and unpublished randomised controlled trials that allocated men, 
women or children undergoing any type of surgery in any setting either  individually 
or by cluster, comparing any antiseptic preparation used for preoperative full body or 
partial body bathing or showering, with non-antiseptic preparations were included. 
Quasi-randomised trials were not included (e.g. trials that allocate treatment by day 
of the week, medical record number, sequential admitting order, etc.). Both authors 
independently assessed the titles and abstracts of references identified by the search 
strategy. Full reports of all potentially relevant trials were then retrieved for 
assessment of eligibility based on the inclusion criteria.  
 
Assessment of methodological quality 
Both authors assessed the quality of eligible trials independently. A pre-defined 
quality assessment tool was used for this purpose and included a rating for allocation 
sequence and concealment, blinding, intention to treat analysis and completeness of 
primary outcome reporting (see Table 1). Disagreements between authors were 
resolved by discussion. When possible, contact was made with investigators of 
included trials to resolve any ambiguities.  
 
Data extraction 
Data were extracted from each study by both authors, independently, using a data 
extraction sheet. We documented information about study design, setting, period, 
type of participants, surgical procedures and the specific nature of the pre-wash 
process. The number of patients developing a post operative wound infection and 
any information about mortality, costs and allergic reactions were also recorded.   
 
Data synthesis 
Analyses were performed using the RevMan 4.2 software. Relative risks and 95% 
confidence intervals (CI) were calculated for dichotomous outcomes, and weighted 
mean differences and 95% CI calculated for continuous outcomes. Results of 
comparable trials were pooled using the fixed-effect model and 95% CI. 
Heterogeneity was investigated by calculating the I2 statistic (15). If evidence of 
significant heterogeneity was identified (a value greater than 50%), potential sources 
of heterogeneity were explored and a random-effects approach to the analysis 
undertaken. A narrative review of eligible studies was conducted where statistical 
synthesis of data from more than one study was not possible or considered 
inappropriate.  
Results 
Our search strategy identified six trials, which were reported in nine publications 
(Fig.1) and contained outcomes for 10,007 participants (16-21). Two of the six trials 
(16, 20) were assessed as being of high methodological quality using our quality 
assessment tool.  
 
Description of studies 
All of the included studies were conducted between 1983 and 1994 (Table 2). The 
age range of the participants was nine to 90 years old. Byrne included clean and 
potentially infected cases but all other studies were of clean surgery (16). Three 
studies included general surgical patients (16,17,20); one included biliary tract, 
inguinal hernia or breast surgery (21). The remaining two studies involved only one 
type of surgery; Earnshaw included patients undergoing vascular reconstruction (18) 
and Randall included only vasectomy patients; participants in the vasectomy trial 
were day case patients (19). All of the studies included the presence of pus in their 
definition of infection. There were inconsistencies in both the interventions and the 
control procedures between studies. One trial compared a regimen that included 
three preoperative washes (16), three trials included a two-wash regimen (17, 18, 
20), and participants in two trials had only one wash preoperatively (19, 21). 
Antibiotic prophylaxis was used routinely in only one study (18). In three other studies 
(16, 20, 21) there was no attempt to alter the treating surgeons' usual routine for 
administering antibiotic prophylaxis but, in these studies, the reported rate of 
prophylactic antibiotic use was low (1% - 15%).  
 
Primary outcome (Surgical site infection) 
Chlorhexidine wash versus wash with placebo 
Three trials of 7691 participants compared chlorhexidine with a placebo (16, 17, 20). 
None of the individual trials found that washing with chlorhexidine had a statistically 
significant effect on surgical site infection. All of the trials were included in the meta-
analysis (Fig.1). When compared with placebo, bathing with chlorhexidine did not 
reduce the surgical site infection rate (chlorhexidine 9.2%, placebo 10.1%); the 
relative risk (RR) was 0.91 (95% confidence interval (CI) 0.80 to 1.04). For this 
outcome we conducted a separate analysis of trials rated as high quality (16, 20) and 
obtained a similar result (Fig. 2), the RR was 0.95 (95% CI 0.82 to 1.10). The event 
rate was 9.3% for the chlorhexidine group and for 9.7% for the placebo group.   
 
Chlorhexidine wash versus wash with non-antiseptic bar soap 
Three trials compared washing with chlorhexidine with washing with bar soap (17-19) 
and included 1443 participants. Significant heterogeneity was present in this 
comparison, so we used a random-effects model for the meta-analysis. Two of the 
trials (18,19) found no difference between the treatments in postoperative surgical 
site infection rate. Hayek (17), reported statistically fewer surgical site infections 
when patients washed preoperatively with chlorhexidine (17); the RR was 0.70 (95% 
CI 0.51 to 0.96). When results of the three trials were combined no differences were 
detected, the RR was 1.02 (95% CI 0.57 to 1.84), an event rate of 10.9% for 
chlorhexidine and 13.6% for bar soap.  
 
Chlorhexidine wash versus no pre-operative wash 
Two trials including 1042 patients were included in this comparison (19, 21). There 
was significant statistical heterogeneity between the two trials (P value < 0.01).  
Randall found no difference in the postoperative surgical site infection rate between 
patients who washed with chlorhexidine compared with patients who did not wash 
preoperatively (19). In the other trial, Wihlborg found that chlorhexidine wash when 
compared with no wash resulted in a reduction in the number of patients with a 
surgical site infection (21); the RR was 0.36 (95% CI 0.17 to 0.79). When the results 
from both trials were combined, washing with an antiseptic showed no overall benefit. 
The event rate for chlorhexidine was 3.7% and when patients did not follow a 
protocol for washing it was 6.2%, the RR was 0.70 (95% CI 0.19 to 2.58). Although 
patients in the no-wash groups were given no instructions to shower or bathe pre-
operatively, it is unclear whether any did so. 
 
More than one wash versus one wash  
The treatment effect for the primary outcome was compared based on number of 
washes before surgery. A total of 7,683 participants in four of the trials had more than 
one wash (16-18, 20). In one trial, 62 patients had one wash (19).  For surgical site 
infection, the effect of chlorhexidine was similar regardless of whether participants 
had more than one wash, RR was 0.91 (95% CI 0.80 to 1.04) or one wash, where the 
RR was 1.13 (95% CI 0.57 to 2.21). The infection rate in both the chlorhexidine group 
(37.5%) and the control group (33.0%) was much higher in patients having one wash 
compared to patients having more than one wash (chlorhexidine 9.3% and control 
10.1%). The most likely explanation for the difference was the broader definition of 
infection that was used in the one wash cohort, the authors included patients with 
either a pus or serous discharge. The confidence intervals for the no wash group 
were also wide, and crossed the no-effect line.  
Secondary outcomes 
Allergic reaction (Chlorhexidine versus placebo) 
One study (16) included allergic reaction as an outcome. There were 19 events 
reported, nine (0.5%) in the chlorhexidine group and 10 (0.6%) in the placebo group; 
no evidence of a statistically significant difference in allergy rate, the RR was 0.89 
(95% CI 0.36 to 2.19).  
 
Mortality 
In the Byrne trial, where chlorhexidine was compared with a placebo, a total of 23 
patients died but they were not reported by group (16). Two patients died in the 
Earnshaw  trial but again, these were not reported by group (18).  
 
Cost  
There was an estimate of cost in one study (16). The average total cost (based on 
drug costs, hotel costs, dressing costs and outpatients' costs) of patients washing 
with chlorhexidine was UK £936 compared with UK £897 when patients washed with 
a placebo. Standard deviations were not reported but, according to the authors, the 
difference was not statistically significant.  
 
Discussion 
Widespread use of preoperative antiseptic washing agents to prevent surgical site 
infection continues. This review summarises trial data from over 10,000 patients, that 
compared washing with chlorhexidine with either a placebo solution, or a bar soap, or 
no preoperative washing at all. There was no evidence that washing with 
chlorhexidine reduced the incidence of surgical site infection. The results of the 
review are strengthened by the heterogeneous nature of the participants; the trials 
included men, women and children undergoing a range of surgeries that were either 
clean or potentially infected, and undertaken in both inpatient and outpatient settings. 
These studies were published over a nine-year period between 1983 and 1992. 
Despite the fact that there have been no recent studies published in this area, it is 
unlikely that further trials would achieve different results. The product used in the 
trials (chlorhexidine 0.4%) remains unchanged and the quality of the two largest trials 
(that included over 6,000 participants) was high, concealing the randomisation 
process and blinding the interventions (16,20). Both of these trials also included 
community follow up.  
 
One of the limitations of the review was the methodological quality of some of the 
studies. Community follow-up was attempted in only three studies (16,19,20), none of 
the authors provided justification for their sample sizes and the study where a cluster 
design was used, analysis was conducted as if participants had been allocated 
individually (17). Ignoring clustering in the analysis may result in an overestimation of 
a positive effect of the intervention (22). This, as well as other quality factors shown 
in Table 2, may explain the positive effect of chlorhexidine over bar soap found by 
Hayek (17) shown in Figure 4. However, in results from the high quality trials and 
from trials where participants were allocated individually, no statistical benefit for the 
use of chlorhexidine for preoperative washing could be demonstrated.  
 
Only one of the trials provided data for other outcomes in which we were interested. 
Byrne assessed complications or undesirable effects attributable to the use of an 
antiseptic. In this trial patients assigned to chlorhexidine use were no more likely to 
suffer an adverse reaction than those assigned to the placebo group (16). There 
were no comparisons with bar soap for this outcome. Byrne also assessed the cost 
of washing with chlorhexidine compared with placebo and found a non-significant 
cost reduction in the placebo group (16). Costs included length of hospital stay, so, 
even though the surgical site infection rate was 1.1% higher in the placebo group, 
using a placebo still resulted in an overall cost benefit.  
  
This review provides evidence of no benefit for pre-operative showering or bathing 
with chlorhexidine over other wash products, to reduce surgical site infection. This 
suggests that efforts to reduce the incidence of nosocomial surgical site infection 
should focus on interventions where effect has been demonstrated (2). Considering 
the number of participants included in this review, it is unlikely that further trials would 
result in any clear benefit for chlorhexidine over other non-antiseptic wash products. 
If any such trial were to be developed, event rates from this review should be used to 
calculate the sample size required to show true differences. 
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Table 1. Quality assessment of included studies. 
 
 
Reference Generation of 
random allocation 
sequence 
Allocation 
concealment 
Blinding of 
intervention 
Blinding of 
outcome 
assessment 
Intention to 
treat analysis
Completeness 
of reporting 
> 90% 
Comments 
Randall (19) Adequate Adequate None Cannot tell Cannot tell Yes  
Hayek (17) Unclear Unclear None Yes Yes Yes Should have 
been analyzed 
by cluster 
Wihlborg (21) Adequate Inadequate None No Cannot tell Yes  
Rotter (20) Adequate Adequate Double Yes Cannot tell Yes  
Earnshaw (18) Unclear Unclear None Yes Cannot tell Yes Different 
instructions 
given to each 
group 
Byrne (16) Adequate Adequate Double Yes Cannot tell Yes  
Reference Year Country Mean age 
(years)* 
Type of 
surgery 
Intervention Follow-up period 
Randall (19) 1983 Single centre, 
Britain 
NR Vasectomy Patients were allocated to one of three groups; 
either one shower with 4% chlorhexidine, one 
shower using soap or no shower. 
1 week after 
hospital discharge 
Hayek (17) 1987 Two hospitals, 
Britain 
56.5/55.0 General All patients showered twice using either 4% 
chlorhexidine, placebo or bar soap 
Until hospital 
discharge 
Wihlborg (21) 1987 Single centre 
Sweden 
NR Biliary, 
inguinal 
hernia or 
breast 
Patients were allocated to one of three groups; 
either one full body wash with 4% chlorhexidine, 
one partial body wash with 4% chlorhexidine or 
no chlorhexidine wash 
Until hospital 
discharge 
Rotter (20) 1988 Multi-centre 
Europe 
NR General All patients showered twice using either 50 mls of 
4% chlorhexidine or placebo 
3 weeks after 
hospital discharge 
Earnshaw (18) 1989 Single centre, 
Britain 
31.0/35.0 Vascular All patients had two baths using either 4% 
chlorhexidine or bar soap 
Until hospital 
discharge 
Byrne (16) 1992 Single centre, 
Britain 
Recorded in 
ranges 
General All patients showered 3 times using either 50mls 
of 4% chlorhexidine or placebo 
6 weeks after 
hospital discharge 
*Data for intervention/control group. NR, not reported 
Table 2. Characteristics of included randomized controlled trials included in meta-analysis 
 
 Not randomized 
controlled trials (n = 27)
Potentially relevant full text of trials 
screened (n = 16) 
Excluded (n = 7) 
Not randomized 
controlled trial (n = 6) 
Both groups used an 
antiseptic solution (n = 1) 
Trials included in the 
meta-analysis n = 6 
(reported in 9 papers) 
Potentially relevant titles and 
abstracts screened (n = 43) 
 
 
Fig. 1 Identification of eligible randomized controlled trials 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Study  Chlorhexidine 4%  Placebo  RR (fixed)  Weight  RR (fixed) 
 n/N  n/N  [95% CI]
 
 %  [95% CI] 
 Rotter 198819       37/1413             33/1400  10.81     1.11 [0.70, 1.77] 
 Byrne 199215      256/1754                272/1735    89.19     0.93 [0.80, 1.09] 
 Total (95% CI) 3167                       3135 100.00     0.95 [0.82, 1.10] 
 0.1  0.2  0.5  1  2  5  10
Favours  
Chlorhexidine 
 Favours 
 placebo
 
 
Figure 2. Chlorhexidine versus placebo (high quality studies only).Number of patients 
developing surgical site infection. Test for heterogeneity: χ2 = 0.50, d.f = 1, P = 0.48 I2 
= 0 per cent. Test for overall effect Z = 0.67. P = 0.50. RR, relative risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study  Chlorhexidine  Placebo  RR (fixed)  Weight  RR (fixed) 
 n/N  n/N [95% CI]
 
 %  [95% CI] 
 
 Hayek 198716         62/689               83/700  21.17      0.76 [0.56, 1.04] 
 Rotter 198819       37/1413           33/1400   8.52     1.11 [0.70, 1.77] 
 Byrne 199215      256/1754          272/1735  70.31     0.93 [0.80, 1.09] 
Total (95% CI) 3856                    3835 100.00     0.91 [0.80, 1.04] 
 0.1  0.2  0.5  1  2  5  10
 Favours  
Chlorhexidine
 
 Favours 
 placebo
 
 
Figure 3. Chlorhexidine versus placebo. Number of patients developing surgical site 
infection (all studies). Test for heterogeneity: χ2 = 2.10, d.f = 2, P = 0.35 I2 = 4.6 per 
cent. Test for overall effect Z = 1.39. P = 0.17. RR, relative risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4. Chlorhexidine versus bar soap. Number of patients developing surgical site 
infection. Test for heterogeneity: χ2 = 5.02, d.f = 2, P = 0.08 I2 = 60.2 per cent. Test 
for overall effect Z = 1.39. P = 0.17. RR, relative risk. 
 
 
  
Study  Chlorhexidine 4%
 
 
Bar soap RR (random)  Weight 
 
 RR (random) 
  n/N  n/N 95% CI  %  95% CI 
 Randall et al198318      12/32           10/30  32.35      1.13 [0.57, 2.21] 
 Hayek et al 198716          62/689          80/626  48.64     0.70 [0.51, 0.96] 
 Earnshaw et al 1989 4/35 17      8/31             19.01     2.26 [0.75, 6.77] 
Total (95% CI)    752             691 100.00     1.02 [0.57, 1.84] 
 0.01  0.1  1  10  100
 Favours CHX  Favours bar soap
 
Study 
 Chlorhexidine 4%  No shower or bath  RR (random)  Weight  RR (random) 
 n/N  n/N  95% CI  %  95% CI 
 Randall 198318       12/32                   9/32  50.71      1.33 [0.65, 2.72] 
 Wihlborg 198720   9/541                20/437  49.29      0.36 [0.17, 0.79] 
Total (95% CI)  573                          469 100.00      0.70 [0.19, 2.58]
 0.01  0.1  1  10  100
 Favours CHX  Favours no shower
 
 
 
Figure 5. Chlorhexidine versus no requested shower or bath. Number of patients 
developing surgical site infection. Test for heterogeneity: χ2 = 6.10, d.f = 1, P = 0.01 I2 
= 83.6 per cent. Test for overall effect Z = 0.53. P = 0.59. RR, relative risk. 
 
 
 
